WeVote
Log In

Bill

Bill

HB 941

Pharmacist Selection and Reimbursement

2025 Regular Session Introduced by Shane Abbott

Died in committee; would have changed Florida pharmacist selection and reimbursement policies affecting pharmacy networks and drug access costs.

Died in Health Care Facilities & Systems Subcommittee
#subjectindex
0
WeVote Research Nonpartisan
Bill Summary · HB 941

Legislative bill overview

HB 941 would have modified Florida's regulations governing how pharmacists are selected and compensated, likely addressing issues around pharmacy network participation and reimbursement rates. The bill died in committee without advancing to a floor vote, indicating insufficient support among legislators.

Why is this important

Pharmacist compensation and selection mechanisms directly affect medication access, pharmacy business viability, and healthcare costs for consumers. Changes to these systems can impact which pharmacies remain operational in underserved areas and influence drug pricing at the retail level.

Potential points of contention

  • Insurance vs. pharmacy interests: Health insurers typically favor broad network restrictions and lower reimbursement rates, while independent pharmacies argue for fair compensation
  • Patient access concerns: Overly restrictive pharmacist selection could limit consumer choice or reduce pharmacy locations in rural/underserved communities
  • Implementation complexity: Reimbursement formula changes require coordination across multiple payers and can create administrative burden for smaller pharmacy operations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.